JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.33, sa.3, ss.170-175, 2017 (SCI-Expanded)
Purpose: To determine the changes in the anterior chamber flare and central macular thickness (CMT) under topical antiglaucomatous therapy.